Retraction: Cancer Cell Int (2019) 19:323 10.1186/s12935-019-1042-4
The Editors-in-Chief have retracted this article. Concerns were raised regarding a number of figures, specifically:
Figure 1e: appears to be overlapped between the panels for HeLa/S sh-NC and HeLa/DDP sh-NC.
Figure 2a appears to contain multiple instances of repeating features.
Figure 2b appears to be also published as Fig. 2B in an article by different authors that was simultaneously under consideration at a different journal [1].
Figure 5c appears to contain data points that were added at different stages.
Figure 6c: the original background for the tumors appears to have been removed.
The Editors-in-Chief therefore no longer have confidence in the results and conclusions of this article.
Corresponding author Jun-li Wang has stated that all authors agree with this retraction.
Footnotes
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xiaoqiong Luo and Jingxi Wei—co-first authors.
Reference
- 1.Gu N, Wang X, Di Z, Xiong J, Ma Y, Yan Y, Qian Y, Zhang Q, Yu J. Silencing lncRNA FOXD2-AS1 inhibits proliferation, migration, invasion and drug resistance of drug-resistant glioma cells and promotes their apoptosis via microRNA-98-5p/CPEB4 axis. Aging (Albany NY) 2019;11:10266–10283. doi: 10.18632/aging.102455. [DOI] [PMC free article] [PubMed] [Google Scholar]